| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/BMM.14.39 |
| P698 | PubMed publication ID | 25402586 |
| P2093 | author name string | Paul Ashwood | |
| Destanie Rose | |||
| P2860 | cites work | The role of immune dysfunction in the pathophysiology of autism | Q22252518 |
| Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin | Q24299103 | ||
| The endophenotype concept in psychiatry: etymology and strategic intentions | Q28187744 | ||
| Gp130 and the interleukin-6 family of cytokines | Q28237653 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| Neuroglial activation and neuroinflammation in the brain of patients with autism | Q29619689 | ||
| Regulation of learning and memory by meningeal immunity: a key role for IL-4 | Q30434189 | ||
| Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children | Q50305915 | ||
| High nitric oxide production in autistic disorder: a possible role for interferon-gamma | Q50341766 | ||
| Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders | Q33925249 | ||
| Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome | Q34348399 | ||
| Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism | Q34411010 | ||
| Cerebrospinal fluid and serum markers of inflammation in autism | Q34448021 | ||
| Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder | Q34587446 | ||
| Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders | Q34645392 | ||
| Historical insights into cytokines | Q34708047 | ||
| Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes | Q34818778 | ||
| The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells | Q35026181 | ||
| Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study | Q35207114 | ||
| Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia | Q35541014 | ||
| Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. | Q35757725 | ||
| Elevated serum levels of interleukin-17A in children with autism. | Q36136811 | ||
| The neuropoietic cytokine family in development, plasticity, disease and injury | Q36740347 | ||
| Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder | Q36741348 | ||
| Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children | Q36992632 | ||
| Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms | Q37146599 | ||
| Immune transcriptome alterations in the temporal cortex of subjects with autism. | Q37218842 | ||
| Macrophage migration inhibitory factor and autism spectrum disorders | Q37277595 | ||
| Elevated immune response in the brain of autistic patients | Q37405256 | ||
| Cytokines and CNS development | Q37617628 | ||
| Medical comorbidities in autism: challenges to diagnosis and treatment | Q37774101 | ||
| Biomarkers in autism spectrum disorder: the old and the new. | Q38149740 | ||
| Depressed lymphocyte responsiveness in autistic children | Q39807754 | ||
| Low-grade endotoxemia in patients with severe autism | Q39907220 | ||
| Cytokine function: a study in biologic diversity | Q40982864 | ||
| Passage of cytokines across the blood-brain barrier | Q41267787 | ||
| Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders | Q44616626 | ||
| Transfer of inflammatory cytokines across the placenta | Q44780433 | ||
| Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort | Q45121530 | ||
| Serum levels of P-selectin in men with high-functioning autism | Q46338488 | ||
| Risk of autism and increasing maternal and paternal age in a large north American population | Q46412203 | ||
| Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank | Q47181557 | ||
| Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study | Q47801374 | ||
| Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism | Q48104813 | ||
| Decreased serum levels of transforming growth factor-beta1 in patients with autism | Q48400459 | ||
| Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism | Q48420054 | ||
| Activation of the inflammatory response system in autism | Q48672746 | ||
| Plasma cytokine levels in children with autistic disorder and unrelated siblings. | Q48750403 | ||
| Altered cytokine and BDNF levels in autism spectrum disorder. | Q50301293 | ||
| P433 | issue | 9 | |
| P921 | main subject | autism | Q38404 |
| biomarker | Q864574 | ||
| autism spectrum disorder | Q1436063 | ||
| P304 | page(s) | 1171-1181 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Biomarkers in Medicine | Q20313333 |
| P1476 | title | Potential cytokine biomarkers in autism spectrum disorders | |
| P478 | volume | 8 |
| Q57456677 | Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism |
| Q38812532 | Cytokine Profile in Autism Spectrum Disorders in Children |
| Q47159621 | Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. |
| Q47127761 | Cytokine profiling in healthy children shows association of age with cytokine concentrations. |
| Q59792265 | Differential T Cell Levels of Tumor Necrosis Factor Receptor-II in Children With Autism |
| Q47564469 | Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment? |
| Q93009864 | Immune network dysregulation associated with child neurodevelopmental delay: modulatory role of prenatal alcohol exposure |
| Q64924784 | Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders. |
| Q39162211 | Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation |
| Q31020010 | Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder |
| Q93108755 | Rapid Communication: Plasma Interleukin-35 in Children with Autism |
| Q38668768 | Serologic Markers of Autism Spectrum Disorder |
| Q57151369 | The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders |
Search more.